Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant
about
Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisMucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.
P2860
Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@ast
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@en
type
label
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@ast
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@en
prefLabel
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@ast
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@en
P2093
P2860
P356
P1433
P1476
Modulation of immunogenicity a ...... mode of lymphotactin adjuvant
@en
P2093
P2860
P304
P356
10.1089/DNA.2011.1367
P577
2011-10-11T00:00:00Z